Meds & supplements › Fruquintinib
Medicine
Fruquintinib
The following clinically significant adverse reactions are described elsewhere in the labeling:
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Drug facts
- Used for
- 1.
- INDICATIONS AND USAGE FRUZAQLA is indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine‑, oxaliplatin‑, and irinotecan‑based chemotherapy, an anti‑VEGF therapy, and, if RAS wild‑type and medically appropriate, an anti-EGFR therapy.
- FRUZAQLA is a kinase inhibitor indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine‑, oxaliplatin‑, and irinotecan‑based chemotherapy, an anti‑VEGF therapy, and, if RAS wild‑type and medically appropriate, an anti-EGFR therapy.
What it is used for
FRUZAQLA is indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine‑, oxaliplatin‑, and irinotecan‑based chemotherapy, an anti‑VEGF therapy, and, if RAS wild‑type and medically appropriate, an anti-EGFR therapy.
Side effects, and when to stop
- Hypertension.
- Hemorrhagic Events.
- Infections.
- Gastrointestinal Perforation.
- Hepatotoxicity.
- Proteinuria.
- Palmar-Plantar Erythrodysesthesia (PPE).
- Posterior Reversible Encephalopathy Syndrome (PRES).
Who should not take it
None.
Storing it
Storage and handling
Store at 20°C to 25°C (68°F to 77°F). Brief exposure to 15°C and 30°C (59°F to 86°F) permitted (see USP Controlled Room Temperature).
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
Cite this page
- NLM
sofidex [Internet]. Daloreum; c2026. Fruquintinib; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/fruquintinib
- APA 7th
sofidex. (2026, August 2). Fruquintinib. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/fruquintinib
- AMA 11th
Fruquintinib. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/fruquintinib
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.